BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.45
+1.88 (1.85%)
At close: Apr 30, 2026, 4:00 PM EDT
96.99
-6.46 (-6.24%)
After-hours: Apr 30, 2026, 7:53 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $26.16 billion as of April 30, 2026. Its market cap has increased by 6.52% in one year.
Market Cap
26.16B
Enterprise Value
10.43B
1-Year Change
6.52%
Ranking
Category
Stock Price
$103.45
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $26.16B, an increase of 773.49%. That is a compound annual growth rate of 39.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 25.69B | 12.21% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.71B |
| Alnylam Pharmaceuticals | 40.19B |
| BeOne Medicines AG | 32.32B |
| Revolution Medicines | 29.56B |
| Royalty Pharma | 29.34B |
| Insmed | 29.15B |
| Incyte | 19.80B |
| Roivant Sciences | 19.70B |